Skip to content Skip to navigation

Senators Request Clarity on mHealth App Regulation from FDA

March 19, 2014
by Gabriel Perna
| Reprints

A group of U.S. Senators have sent a letter to Food and Drug Administration (FDA) Commissioner, Margaret A. Hamburg, M.D. seeking further clarity and transparency on how the agency plans on regulating medical mobile health (mHealth) apps.

Senators Michael Bennet (D-Colo.), Orrin Hatch (R-Utah), Tom Harkin (D-Iowa), Lamar Alexander (R-Tenn), Mark Warner (D-Va), and Richard Burr (R-NC) sent the letter to Dr. Hamburg, asking for further clarification  for medical software application developers. Referring to the FDA's final guidance over mHealth apps, the Senators note that the agency used a risk-based approach in defining what it considers to be a mobile medical application, focused on high-risk medical software in particular. The Senators say a large number of apps could be actively regulated under this definition and more transparency is required for developers.

"While the FDA’s final guidance has provided clarity on the agency’s approach to regulation of mobile medical applications, we believe more transparency is needed to avoid stakeholder confusion over how a wider range of medical software might be appropriately regulated," the Senators wrote in the letter.

The Senators include a series of questions within the letter that it requests the FDA answer within three weeks of its receipt. Some of those questions include:

  • Compared to current FDA guidance, what impact would Congress establishing categories of medical software in legislation have on the FDA’s oversight of medical mobile applications?
  • What role, if any, can statutory definitions play to clarify any uncertainty with respect to assigning risk level to medical software?

  • How is the FDA determining what types of medical software updates, even minor updates, change the function of or add a function to the medical software and would require FDA review?

  • How has the FDA been coordinating with the Office of the National Coordinator and Federal Communications Commission to address the recent FDA Safety and Innovation Act working group’s concerns over interoperability?

The letter, in its entirety, can be read by clicking the link below.

 

Read the source article at Michael Bennet

Topics

News

Lenovo Health and Orbita Launch Voice-Enabled Home Health Assistant Technology

North Carolina-based health IT company Lenovo Health and Orbita, a Boston-based connected home healthcare company, launched a virtual home care solution and showcased the technology at HIMSS17 in Orlando.

Phase 2 Winners Chosen in ‘Move Health Data Forward’ Challenge

The Office of the National Coordinator for Health Information Technology has announced five winners in Phase 2 of the “Move Health Data Forward” Challenge, a contest to develop solutions to help with the flow of health information.

National Association for Trusted Exchange Unveils FHIR-Based Solution for Data Sharing

At the HIMSS17 conference in Orlando on Monday, The National Association for Trusted Exchange (NATE) unveiled NATE’s Blue Button Directory (NBBD) and is demonstrating it as part of the Federal Health Architecture’s demonstrations in the HIMSS17 Interoperability Showcase.

Health Catalyst Incorporates Regenstrief’s NLP Solution in Its Analytics Platform

At the HIMSS17 conference in Orlando, the nonprofit Regenstrief Institute announced a partnership with analytics vendor Health Catalyst involving Regenstrief's artificial intelligence-powered text analytics technology.

Survey: Cybersecurity Getting More Attention at the C-Suite and Board Level

Cybersecurity has been elevated to a central concern for healthcare providers, with more attention at the board level and the C-suite, according to a new survey by Orem, Utah-based KLAS Research and the College of Healthcare Information Management Executives (CHIME). The study found that 42 percent of organizations have a vice president or C-level official in charge of cybersecurity and for 39 percent of organizations, the head of cybersecurity is at the director level.

Partnership for Health IT Patient Safety Focuses on Patient Identification

The Partnership for Health IT Patient Safety has rolled out its second set of Safe Practice Recommendations with a focus on reducing patient misidentification.